Recordati SpA 

$16.87
166
+$1.08+6.81% Tuesday 19:52

Statistics

Day High
15.8
Day Low
15.8
52W High
17.04
52W Low
10.34
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
25.81
Dividend Yield
2.3%
Dividend
0.39

Upcoming

Dividends

2.3%Dividend Yield
Jun 26
$0.21
Dec 25
$0.18
Jun 25
$0.19
Dec 24
$0.16
Jun 24
$0.17
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
35.9%
1Y Growth
4.28%

Earnings

12MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.58
0.65
0.73
0.8
Expected EPS
N/A
Actual EPS
N/A

Financials

17.82%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
4.94BRevenue
880.32MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RICFY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap279.67B
Novartis is a global healthcare company that competes with Recordati in the pharmaceuticals sector, particularly in the development and marketing of prescription medications.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a large pharmaceutical company that competes directly with Recordati in the development and distribution of drugs across various therapeutic areas.
Merck
MRK
Mkt Cap277.02B
Merck & Co. is a leading pharmaceutical company that competes with Recordati in the research, development, and marketing of drugs, especially in the areas of cardiovascular diseases.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie competes with Recordati in the pharmaceutical industry, particularly in the development of therapies for diseases in areas like immunology and oncology, which may overlap with Recordati's product offerings.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline is a global healthcare company that competes with Recordati in the pharmaceutical and healthcare sector, including the development of medications for various diseases.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company that competes with Recordati in the development and marketing of prescription medicines, particularly in the cardiovascular, renal, and metabolism therapeutic areas.
Sanofi
SNY
Mkt Cap110.4B
Sanofi is a global healthcare leader that competes with Recordati in the pharmaceutical sector, offering a wide range of prescription medicines, vaccines, and over-the-counter healthcare products.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Recordati in the discovery, development, and delivery of medicines in areas such as cardiovascular, oncology, and immunoscience.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson is a diversified healthcare giant that competes with Recordati not only in the pharmaceutical sector but also in consumer health products and medical devices.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Recordati in the generic drug market and in the development of specialty pharmaceuticals.

About

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
Show more...
CEO
Dr. Robert Koremans M.D.
Employees
4580
Country
Italy
ISIN
US75625L1008

Listings

0 Comments

Share your thoughts

FAQ

What is Recordati SpA stock price today?
The current price of RICFY is $16.87 USD — it has increased by +6.81% in the past 24 hours. Watch Recordati SpA stock price performance more closely on the chart.
What is Recordati SpA stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Recordati SpA stocks are traded under the ticker RICFY.
Is Recordati SpA stock price growing?
RICFY stock has risen by +42.12% compared to the previous week, the month change is a +17.23% rise, over the last year Recordati SpA has showed a +16.34% increase.
When is the next Recordati SpA earnings date?
Recordati SpA is going to release the next earnings report on May 12, 2026.
What is Recordati SpA revenue for the last year?
Recordati SpA revenue for the last year amounts to 4.94B USD.
What is Recordati SpA net income for the last year?
RICFY net income for the last year is 880.32M USD.
Does Recordati SpA pay dividends?
Yes, RICFY dividends are paid semi-annual. The last dividend per share was 0.18 USD. As of today, Dividend Yield (FWD)% is 2.3%.
How many employees does Recordati SpA have?
As of May 06, 2026, the company has 4,580 employees.
In which sector is Recordati SpA located?
Recordati SpA operates in the Health & Wellness sector.
When did Recordati SpA complete a stock split?
Recordati SpA has not had any recent stock splits.
Where is Recordati SpA headquartered?
Recordati SpA is headquartered in Milan, Italy.